Impact of Web-based Care Management for Poorly Controlled Type 2 Diabetes Mellitus: a Randomized, Controlled Trial
Withdrawn before enrolling · Not applicable
Conditions studied: Type 2 Diabetes Mellitus
In brief
Between October 1 and November 30, 2011, participants will be enrolled in this study comparing the use of MyLink web-based care with usual CPS care. Patients age 18- 74 with HbA1c ≥ 9% in the last 12 months will be identified. It is expected that approximately 32 people (16 per group) will participate in the study. Once eligible patients are found, they will be randomly assigned (like the flip of a coin) to usual care with the CPS or usual care with the CPS plus web-based care using the MyLink software. Participants using the software will agree to upload their glucometer measurements using the software every 2- 4 weeks. Following the receipt of the glucometer data, either electronically from intervention group participants or verbally from the control group participants, medications/ doses will be adjusted by the pharmacist as needed to achieve HbA1c goals. Participants in both groups will receive a follow-up HbA1c 2-4 months after enrollment to see if there were any significant changes in HbA1c between groups.
Key facts
- Study ID
- NCT01960062
- Run by
- Kaiser Permanente
- People needed
- 0
- Starts
- 2011-10-01
- Expected to finish
- 2012-06-01
- Last updated by the study team
- 2014-03-19
Who can join
Age: 18 and older, up to 74. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Receiving care from a PCP at the specified KPGA medical centers
- 18-74 years of age
- Type 2 Diabetes Mellitus (DM)
- Treated with insulin or willing to start insulin therapy
- Most recent HbA1c in the previous 12 months ≥ 9%
- Internet capability
- Actively enrolled or willing to enroll on www.kp.org
- English speaking
You may not qualify if…
- Having received care from an endocrinology specialty physician or Hospice/ Palliative Care within the last 3 months
- Enrolled in another research study
- Using an insulin pump
- Type 1 DM
Where it is running
- Kaiser Permanente Georgia Region — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.